Poirier to acquire Biophelia

Pharmaceutical company Laboratoires Pharmaceutiques Poirier acquired its competitor Biophelia, part of NextPharma group, for €3.5m. According to French daily Les Echos, which reported the news, the acquisition, in fact, saves Biophelia from bankruptcy. (Source Les Echos)